Search

everythinglearnresearchcommunity

for

Search:↓

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Polysaccharides have many health benefits and are used in drugs, but isolating and purifying them is complex and requires careful methods.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Dupilumab helps children with alopecia areata regrow hair safely.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Hair absorbs different substances from solutions based on pH levels.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Hair absorbs alkali bromide salts and water, affecting its structure, with absorption decreasing at higher temperatures.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

All wiping methods are as effective as washing for removing cleaning agent from hair.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Rituximab can cause skin issues, but baricitinib may help improve them.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.